{"entity":{"type":"insider","cik":"0001758790","url":"/insider/0001758790","json_url":"/insider/0001758790.json","name":"Sablich Kim","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":6,"first":"2019-12-19","last":"2023-03-10","span_basis":"filed_date"},"name_variants":[{"name":"Sablich Kim","source":"filing","n_filings":6,"first_seen":"2019-12-19","last_seen":"2023-03-10"}],"transactions":[{"id":8512761,"accession":"0001765581-23-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-23-000036","line_url":"/filing/0001765581-23-000036","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001758790","owner_name":"Sablich Kim","owner_display_name":"Sablich Kim","owner_url":"/insider/0001758790","role":"Officer (EVP, GM of U.S., Commercial Ma)","role_mark":"O","role_mark_label":"Officer (EVP, GM of U.S., Commercial Ma)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GM of U.S., Commercial Ma","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3013.0,"shares_display":"3,013","price_per_share":139.74226020577498,"price_display":"139.74","price_state":"stated","total_value":421043.43,"total_display":"421,043.43","total_whole":"421,043","shares_owned_after":31821.0,"shares_owned_after_display":"31,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-08","filed_date":"2023-03-10","scope":"insider","n_lines":2},{"id":6989531,"accession":"0001765581-22-000057","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001765581-22-000057","line_url":"/filing/0001765581-22-000057","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001758790","owner_name":"Sablich Kim","owner_display_name":"Sablich Kim","owner_url":"/insider/0001758790","role":"Officer (EVP & GM, North America)","role_mark":"O","role_mark_label":"Officer (EVP & GM, North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GM, North America","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2441.0,"shares_display":"2,441","price_per_share":151.05020503891848,"price_display":"151.05","price_state":"stated","total_value":368713.5505,"total_display":"368,713.55","total_whole":"368,714","shares_owned_after":24855.0,"shares_owned_after_display":"24,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-07","filed_date":"2022-06-08","scope":"insider","n_lines":5},{"id":6989519,"accession":"0001765581-22-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-22-000057","line_url":"/filing/0001765581-22-000057#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001758790","owner_name":"Sablich Kim","owner_display_name":"Sablich Kim","owner_url":"/insider/0001758790","role":"Officer (EVP & GM, North America)","role_mark":"O","role_mark_label":"Officer (EVP & GM, North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GM, North America","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1388.0,"shares_display":"1,388","price_per_share":152.15,"price_display":"152.15","price_state":"stated","total_value":211184.2,"total_display":"211,184.20","total_whole":"211,184","shares_owned_after":27195.0,"shares_owned_after_display":"27,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":4580944,"accession":"0001765581-21-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001765581-21-000125","line_url":"/filing/0001765581-21-000125#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001758790","owner_name":"Sablich Kim","owner_display_name":"Sablich Kim","owner_url":"/insider/0001758790","role":"Officer (EVP & GM, North America)","role_mark":"O","role_mark_label":"Officer (EVP & GM, North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GM, North America","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2748.0,"shares_display":"2,748","price_per_share":135.0074,"price_display":"135.01","price_state":"stated","total_value":371000.3352,"total_display":"371,000.34","total_whole":"371,000","shares_owned_after":21135.0,"shares_owned_after_display":"21,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-11-15","scope":"insider"},{"id":3088466,"accession":"0001209191-20-020279","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-020279","line_url":"/filing/0001209191-20-020279","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001758790","owner_name":"Sablich Kim","owner_display_name":"Sablich Kim","owner_url":"/insider/0001758790","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":785.0,"shares_display":"785","price_per_share":7.3714012738853505,"price_display":"7.37","price_state":"stated","total_value":5786.55,"total_display":"5,786.55","total_whole":"5,787","shares_owned_after":58920.0,"shares_owned_after_display":"58,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-18","filed_date":"2020-03-19","scope":"insider","n_lines":2},{"id":3233473,"accession":"0001209191-20-003741","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-003741","line_url":"/filing/0001209191-20-003741#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001758790","owner_name":"Sablich Kim","owner_display_name":"Sablich Kim","owner_url":"/insider/0001758790","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4840.0,"shares_display":"4,840","price_per_share":14.04,"price_display":"14.04","price_state":"stated","total_value":67953.6,"total_display":"67,953.60","total_whole":"67,954","shares_owned_after":59690.0,"shares_owned_after_display":"59,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-15","filed_date":"2020-01-16","scope":"insider"},{"id":8210795,"accession":"0001209191-19-061300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-061300","line_url":"/filing/0001209191-19-061300#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001758790","owner_name":"Sablich Kim","owner_display_name":"Sablich Kim","owner_url":"/insider/0001758790","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2585.0,"shares_display":"2,585","price_per_share":16.22,"price_display":"16.22","price_state":"stated","total_value":41928.7,"total_display":"41,928.70","total_whole":"41,929","shares_owned_after":64530.0,"shares_owned_after_display":"64,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001232524","name":"Jazz Pharmaceuticals plc","url":"/issuer/0001232524","role":"Officer (EVP, GM of U.S., Commercial Ma)","n_filings":3,"first_seen":"2021-11-15","last_seen":"2023-03-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001679082","name":"Myovant Sciences Ltd.","url":"/issuer/0001679082","role":"Officer (Chief Commercial Officer)","n_filings":3,"first_seen":"2019-12-19","last_seen":"2020-03-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001758790","retrieved_at":"2026-08-22T18:21:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}